Skip to main content
Erschienen in: European Journal of Nutrition 2/2017

22.06.2016 | Review

Celiac disease: understanding the gluten-free diet

verfasst von: Karla A. Bascuñán, María Catalina Vespa, Magdalena Araya

Erschienen in: European Journal of Nutrition | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The only effective and safe treatment of celiac disease (CD) continues being strict exclusion of gluten for life, the so-called gluten-free diet (GFD). Although this treatment is highly successful, following strict GFD poses difficulties to patients in family, social and working contexts, deteriorating his/her quality of life. We aimed to review main characteristics of GFD with special emphasis on factors that may interfere with adherence to it.

Methods

We conducted a search of various databases, such as PubMed, Google Scholar, Embase, and Scielo, with focus on key words such as “gluten-free diet”, “celiac disease”, “gluten” and “gluten-free diet adherence”. Available literature has not reached definitive conclusions on the exact amount of gluten that is harmless to celiac patients, although international agreements establish cutoff points for gluten-free products and advise the use of clinical assessment to tailor the diet according to individual needs. Following GFD must include eliminating gluten as ingredient as well as hidden component and potential cross contamination in foods. There are numerous grains to substitute wheat but composition of most gluten-free products tends to include only a small number of them, especially rice. The diet must be not only free of gluten but also healthy to avoid nutrient, vitamins and minerals deficiencies or excess. Overweight/obesity frequency has increased among celiac patients so weight gain deserves attention during follow up. Nutritional education by a trained nutritionist is of great relevance to achieve long-term satisfactory health status and good compliance.

Conclusions

A balanced GFD should be based on a combination of naturally gluten-free foods and certified processed gluten-free products. How to measure and improve adherence to GFD is still controversial and deserves further study.
Literatur
5.
Zurück zum Zitat Catassi C, Ratsch IM, Gandolfi L, Pratesi R, Fabiani E, El Asmar R, Frijia M, Bearzi I, Vizzoni L (1999) Why is coeliac disease endemic in the people of the Sahara? Lancet 354(9179):647–648CrossRef Catassi C, Ratsch IM, Gandolfi L, Pratesi R, Fabiani E, El Asmar R, Frijia M, Bearzi I, Vizzoni L (1999) Why is coeliac disease endemic in the people of the Sahara? Lancet 354(9179):647–648CrossRef
6.
Zurück zum Zitat Ciacci C, Cirillo M, Cavallaro R, Mazzacca G (2002) Long-term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage. Digestion 66(3):178–185. doi:10.1159/000066757 CrossRef Ciacci C, Cirillo M, Cavallaro R, Mazzacca G (2002) Long-term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage. Digestion 66(3):178–185. doi:10.​1159/​000066757 CrossRef
9.
Zurück zum Zitat Parnell ND, Ciclitira PJ (1999) Review article: coeliac disease and its management. Aliment Pharmacol Ther 13(1):1–13CrossRef Parnell ND, Ciclitira PJ (1999) Review article: coeliac disease and its management. Aliment Pharmacol Ther 13(1):1–13CrossRef
10.
Zurück zum Zitat Hallert C, Grant C, Grehn S, Granno C, Hulten S, Midhagen G, Strom M, Svensson H, Valdimarsson T (2002) Evidence of poor vitamin status in coeliac patients on a gluten-free diet for 10 years. Aliment Pharmacol Ther 16(7):1333–1339CrossRef Hallert C, Grant C, Grehn S, Granno C, Hulten S, Midhagen G, Strom M, Svensson H, Valdimarsson T (2002) Evidence of poor vitamin status in coeliac patients on a gluten-free diet for 10 years. Aliment Pharmacol Ther 16(7):1333–1339CrossRef
11.
Zurück zum Zitat Kupper C (2005) Dietary guidelines and implementation for celiac disease. Gastroenterology 128(4 Suppl 1):S121–S127CrossRef Kupper C (2005) Dietary guidelines and implementation for celiac disease. Gastroenterology 128(4 Suppl 1):S121–S127CrossRef
12.
14.
Zurück zum Zitat La Vieille S, Dubois S, Hayward S, Koerner TB (2014) Estimated levels of gluten incidentally present in a Canadian gluten-free diet. Nutrients 6(2):881–896. doi:10.3390/nu6020881 CrossRef La Vieille S, Dubois S, Hayward S, Koerner TB (2014) Estimated levels of gluten incidentally present in a Canadian gluten-free diet. Nutrients 6(2):881–896. doi:10.​3390/​nu6020881 CrossRef
15.
Zurück zum Zitat Catassi C, Bai JC, Bonaz B, Bouma G, Calabro A, Carroccio A, Castillejo G, Ciacci C, Cristofori F, Dolinsek J, Francavilla R, Elli L, Green P, Holtmeier W, Koehler P, Koletzko S, Meinhold C, Sanders D, Schumann M, Schuppan D, Ullrich R, Vecsei A, Volta U, Zevallos V, Sapone A, Fasano A (2013) Non-celiac gluten sensitivity: the new frontier of gluten related disorders. Nutrients 5(10):3839–3853. doi:10.3390/nu5103839 CrossRef Catassi C, Bai JC, Bonaz B, Bouma G, Calabro A, Carroccio A, Castillejo G, Ciacci C, Cristofori F, Dolinsek J, Francavilla R, Elli L, Green P, Holtmeier W, Koehler P, Koletzko S, Meinhold C, Sanders D, Schumann M, Schuppan D, Ullrich R, Vecsei A, Volta U, Zevallos V, Sapone A, Fasano A (2013) Non-celiac gluten sensitivity: the new frontier of gluten related disorders. Nutrients 5(10):3839–3853. doi:10.​3390/​nu5103839 CrossRef
16.
Zurück zum Zitat Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PH, Hadjivassiliou M, Kaukinen K, Kelly CP, Leonard JN, Lundin KE, Murray JA, Sanders DS, Walker MM, Zingone F, Ciacci C (2013) The Oslo definitions for coeliac disease and related terms. Gut 62(1):43–52. doi:10.1136/gutjnl-2011-301346 CrossRef Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PH, Hadjivassiliou M, Kaukinen K, Kelly CP, Leonard JN, Lundin KE, Murray JA, Sanders DS, Walker MM, Zingone F, Ciacci C (2013) The Oslo definitions for coeliac disease and related terms. Gut 62(1):43–52. doi:10.​1136/​gutjnl-2011-301346 CrossRef
18.
Zurück zum Zitat Ontiveros N, Lopez-Gallardo JA, Vergara-Jimenez MJ, Cabrera-Chavez F (2015) Self-reported prevalence of symptomatic adverse reactions to gluten and adherence to gluten-free diet in an Adult Mexican Population. Nutrients 7(7):6000–6015. doi:10.3390/nu7075267 CrossRef Ontiveros N, Lopez-Gallardo JA, Vergara-Jimenez MJ, Cabrera-Chavez F (2015) Self-reported prevalence of symptomatic adverse reactions to gluten and adherence to gluten-free diet in an Adult Mexican Population. Nutrients 7(7):6000–6015. doi:10.​3390/​nu7075267 CrossRef
19.
Zurück zum Zitat Volta U, Bardella MT, Calabro A, Troncone R, Corazza GR, Study Group for Non-Celiac Gluten S (2014) An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Med 12:85. doi:10.1186/1741-7015-12-85 CrossRef Volta U, Bardella MT, Calabro A, Troncone R, Corazza GR, Study Group for Non-Celiac Gluten S (2014) An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Med 12:85. doi:10.​1186/​1741-7015-12-85 CrossRef
20.
Zurück zum Zitat Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M, Kaukinen K, Rostami K, Sanders DS, Schumann M, Ullrich R, Villalta D, Volta U, Catassi C, Fasano A (2012) Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med 10:13. doi:10.1186/1741-7015-10-13 CrossRef Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M, Kaukinen K, Rostami K, Sanders DS, Schumann M, Ullrich R, Villalta D, Volta U, Catassi C, Fasano A (2012) Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med 10:13. doi:10.​1186/​1741-7015-10-13 CrossRef
23.
Zurück zum Zitat Jones SM, Magnolfi CF, Cooke SK, Sampson HA (1995) Immunologic cross-reactivity among cereal grains and grasses in children with food hypersensitivity. J Allergy Clin Immunol 96(3):341–351CrossRef Jones SM, Magnolfi CF, Cooke SK, Sampson HA (1995) Immunologic cross-reactivity among cereal grains and grasses in children with food hypersensitivity. J Allergy Clin Immunol 96(3):341–351CrossRef
24.
Zurück zum Zitat Matricardi PM, Bockelbrink A, Beyer K, Keil T, Niggemann B, Gruber C, Wahn U, Lau S (2008) Primary versus secondary immunoglobulin E sensitization to soy and wheat in the Multi-Centre Allergy Study cohort. Clin Exp Allergy J Br Soc Allergy Clin Immunol 38(3):493–500. doi:10.1111/j.1365-2222.2007.02912.x CrossRef Matricardi PM, Bockelbrink A, Beyer K, Keil T, Niggemann B, Gruber C, Wahn U, Lau S (2008) Primary versus secondary immunoglobulin E sensitization to soy and wheat in the Multi-Centre Allergy Study cohort. Clin Exp Allergy J Br Soc Allergy Clin Immunol 38(3):493–500. doi:10.​1111/​j.​1365-2222.​2007.​02912.​x CrossRef
27.
Zurück zum Zitat Lis DM, Stellingwerff T, Shing CM, Ahuja KD, Fell JW (2015) Exploring the popularity, experiences, and beliefs surrounding gluten-free diets in nonceliac athletes. Int J Sport Nutr Exerc Metab 25(1):37–45. doi:10.1123/ijsnem.2013-0247 CrossRef Lis DM, Stellingwerff T, Shing CM, Ahuja KD, Fell JW (2015) Exploring the popularity, experiences, and beliefs surrounding gluten-free diets in nonceliac athletes. Int J Sport Nutr Exerc Metab 25(1):37–45. doi:10.​1123/​ijsnem.​2013-0247 CrossRef
29.
Zurück zum Zitat Greco L (1997) From the neolithic revolution to gluten intolerance: benefits and problems associated with the cultivation of wheat. J Pediatr Gastroenterol Nutr 24(5):S14–S16 (discussion S16-17) CrossRef Greco L (1997) From the neolithic revolution to gluten intolerance: benefits and problems associated with the cultivation of wheat. J Pediatr Gastroenterol Nutr 24(5):S14–S16 (discussion S16-17) CrossRef
30.
Zurück zum Zitat van den Broeck HC, van Herpen TW, Schuit C, Salentijn EM, Dekking L, Bosch D, Hamer RJ, Smulders MJ, Gilissen LJ, van der Meer IM (2009) Removing celiac disease-related gluten proteins from bread wheat while retaining technological properties: a study with Chinese Spring deletion lines. BMC Plant Biol 9:41. doi:10.1186/1471-2229-9-41 CrossRef van den Broeck HC, van Herpen TW, Schuit C, Salentijn EM, Dekking L, Bosch D, Hamer RJ, Smulders MJ, Gilissen LJ, van der Meer IM (2009) Removing celiac disease-related gluten proteins from bread wheat while retaining technological properties: a study with Chinese Spring deletion lines. BMC Plant Biol 9:41. doi:10.​1186/​1471-2229-9-41 CrossRef
31.
Zurück zum Zitat Ang S, Kogulanathan J, Morris GA, Kok MS, Shewry PR, Tatham AS, Adams GG, Rowe AJ, Harding SE (2010) Structure and heterogeneity of gliadin: a hydrodynamic evaluation. Eur Biophys J 39(2):255–261. doi:10.1007/s00249-009-0529-7 CrossRef Ang S, Kogulanathan J, Morris GA, Kok MS, Shewry PR, Tatham AS, Adams GG, Rowe AJ, Harding SE (2010) Structure and heterogeneity of gliadin: a hydrodynamic evaluation. Eur Biophys J 39(2):255–261. doi:10.​1007/​s00249-009-0529-7 CrossRef
32.
Zurück zum Zitat Frisoni M, Corazza GR, Lafiandra D, De Ambrogio E, Filipponi C, Bonvicini F, Borasio E, Porceddu E, Gasbarrini G (1995) Wheat deficient in gliadins: promising tool for treatment of coeliac disease. Gut 36(3):375–378CrossRef Frisoni M, Corazza GR, Lafiandra D, De Ambrogio E, Filipponi C, Bonvicini F, Borasio E, Porceddu E, Gasbarrini G (1995) Wheat deficient in gliadins: promising tool for treatment of coeliac disease. Gut 36(3):375–378CrossRef
33.
Zurück zum Zitat Spaenij-Dekking L, Kooy-Winkelaar Y, van Veelen P, Drijfhout JW, Jonker H, van Soest L, Smulders MJ, Bosch D, Gilissen LJ, Koning F (2005) Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology 129(3):797–806. doi:10.1053/j.gastro.2005.06.017 CrossRef Spaenij-Dekking L, Kooy-Winkelaar Y, van Veelen P, Drijfhout JW, Jonker H, van Soest L, Smulders MJ, Bosch D, Gilissen LJ, Koning F (2005) Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology 129(3):797–806. doi:10.​1053/​j.​gastro.​2005.​06.​017 CrossRef
34.
Zurück zum Zitat Carroccio A, Di Prima L, Noto D, Fayer F, Ambrosiano G, Villanacci V, Lammers K, Lafiandra D, De Ambrogio E, Di Fede G, Iacono G, Pogna N (2011) Searching for wheat plants with low toxicity in celiac disease: between direct toxicity and immunologic activation. Dig Liver Dis 43(1):34–39. doi:10.1016/j.dld.2010.05.005 CrossRef Carroccio A, Di Prima L, Noto D, Fayer F, Ambrosiano G, Villanacci V, Lammers K, Lafiandra D, De Ambrogio E, Di Fede G, Iacono G, Pogna N (2011) Searching for wheat plants with low toxicity in celiac disease: between direct toxicity and immunologic activation. Dig Liver Dis 43(1):34–39. doi:10.​1016/​j.​dld.​2010.​05.​005 CrossRef
36.
Zurück zum Zitat Mitea C, Salentijn EM, van Veelen P, Goryunova SV, van der Meer IM, van den Broeck HC, Mujico JR, Montserrat V, Gilissen LJ, Drijfhout JW, Dekking L, Koning F, Smulders MJ (2010) A universal approach to eliminate antigenic properties of alpha-gliadin peptides in celiac disease. PLoS One 5(12):e15637. doi:10.1371/journal.pone.0015637 CrossRef Mitea C, Salentijn EM, van Veelen P, Goryunova SV, van der Meer IM, van den Broeck HC, Mujico JR, Montserrat V, Gilissen LJ, Drijfhout JW, Dekking L, Koning F, Smulders MJ (2010) A universal approach to eliminate antigenic properties of alpha-gliadin peptides in celiac disease. PLoS One 5(12):e15637. doi:10.​1371/​journal.​pone.​0015637 CrossRef
37.
Zurück zum Zitat Auricchio S, De Ritis G, De Vincenzi M, Occorsio P, Silano V (1982) Effects of gliadin-derived peptides from bread and durum wheats on small intestine cultures from rat fetus and coeliac children. Pediatr Res 16(12):1004–1010CrossRef Auricchio S, De Ritis G, De Vincenzi M, Occorsio P, Silano V (1982) Effects of gliadin-derived peptides from bread and durum wheats on small intestine cultures from rat fetus and coeliac children. Pediatr Res 16(12):1004–1010CrossRef
39.
Zurück zum Zitat Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P (2001) Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2(4):361–367. doi:10.1038/86373 CrossRef Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P (2001) Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2(4):361–367. doi:10.​1038/​86373 CrossRef
40.
Zurück zum Zitat Ciccocioppo R, Di Sabatino A, Parroni R, D’Alo S, Pistoia MA, Doglioni C, Cifone MG, Corazza GR (2000) Cytolytic mechanisms of intraepithelial lymphocytes in coeliac disease (CoD). Clin Exp Immunol 120(2):235–240CrossRef Ciccocioppo R, Di Sabatino A, Parroni R, D’Alo S, Pistoia MA, Doglioni C, Cifone MG, Corazza GR (2000) Cytolytic mechanisms of intraepithelial lymphocytes in coeliac disease (CoD). Clin Exp Immunol 120(2):235–240CrossRef
41.
Zurück zum Zitat Di Sabatino A, Ciccocioppo R, Cupelli F, Cinque B, Millimaggi D, Clarkson MM, Paulli M, Cifone MG, Corazza GR (2006) Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 55(4):469–477. doi:10.1136/gut.2005.068684 CrossRef Di Sabatino A, Ciccocioppo R, Cupelli F, Cinque B, Millimaggi D, Clarkson MM, Paulli M, Cifone MG, Corazza GR (2006) Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 55(4):469–477. doi:10.​1136/​gut.​2005.​068684 CrossRef
42.
Zurück zum Zitat Salvati VM, Mazzarella G, Gianfrani C, Levings MK, Stefanile R, De Giulio B, Iaquinto G, Giardullo N, Auricchio S, Roncarolo MG, Troncone R (2005) Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa. Gut 54(1):46–53. doi:10.1136/gut.2003.023150 CrossRef Salvati VM, Mazzarella G, Gianfrani C, Levings MK, Stefanile R, De Giulio B, Iaquinto G, Giardullo N, Auricchio S, Roncarolo MG, Troncone R (2005) Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa. Gut 54(1):46–53. doi:10.​1136/​gut.​2003.​023150 CrossRef
43.
44.
Zurück zum Zitat Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, Raulet DH, Lanier LL, Groh V, Spies T, Ebert EC, Green PH, Jabri B (2004) Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21(3):357–366. doi:10.1016/j.immuni.2004.06.020 CrossRef Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, Raulet DH, Lanier LL, Groh V, Spies T, Ebert EC, Green PH, Jabri B (2004) Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21(3):357–366. doi:10.​1016/​j.​immuni.​2004.​06.​020 CrossRef
45.
Zurück zum Zitat Pagliari D, Cianci R, Frosali S, Landolfi R, Cammarota G, Newton EE, Pandolfi F (2013) The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response. Cytokine Growth Factor Rev 24(5):455–466. doi:10.1016/j.cytogfr.2013.05.004 CrossRef Pagliari D, Cianci R, Frosali S, Landolfi R, Cammarota G, Newton EE, Pandolfi F (2013) The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response. Cytokine Growth Factor Rev 24(5):455–466. doi:10.​1016/​j.​cytogfr.​2013.​05.​004 CrossRef
46.
Zurück zum Zitat Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, Verkarre V, Fodil N, Bahram S, Cerf-Bensussan N, Caillat-Zucman S (2004) A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21(3):367–377. doi:10.1016/j.immuni.2004.06.018 CrossRef Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, Verkarre V, Fodil N, Bahram S, Cerf-Bensussan N, Caillat-Zucman S (2004) A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21(3):367–377. doi:10.​1016/​j.​immuni.​2004.​06.​018 CrossRef
47.
Zurück zum Zitat Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M (2000) Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 119(4):996–1006CrossRef Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M (2000) Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 119(4):996–1006CrossRef
48.
Zurück zum Zitat Benahmed M, Meresse B, Arnulf B, Barbe U, Mention JJ, Verkarre V, Allez M, Cellier C, Hermine O, Cerf-Bensussan N (2007) Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 132(3):994–1008. doi:10.1053/j.gastro.2006.12.025 CrossRef Benahmed M, Meresse B, Arnulf B, Barbe U, Mention JJ, Verkarre V, Allez M, Cellier C, Hermine O, Cerf-Bensussan N (2007) Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 132(3):994–1008. doi:10.​1053/​j.​gastro.​2006.​12.​025 CrossRef
50.
Zurück zum Zitat Daum S, Bauer U, Foss HD, Schuppan D, Stein H, Riecken EO, Ullrich R (1999) Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 44(1):17–25CrossRef Daum S, Bauer U, Foss HD, Schuppan D, Stein H, Riecken EO, Ullrich R (1999) Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 44(1):17–25CrossRef
51.
Zurück zum Zitat Junker Y, Zeissig S, Kim SJ, Barisani D, Wieser H, Leffler DA, Zevallos V, Libermann TA, Dillon S, Freitag TL, Kelly CP, Schuppan D (2012) Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med 209(13):2395–2408. doi:10.1084/jem.20102660 CrossRef Junker Y, Zeissig S, Kim SJ, Barisani D, Wieser H, Leffler DA, Zevallos V, Libermann TA, Dillon S, Freitag TL, Kelly CP, Schuppan D (2012) Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med 209(13):2395–2408. doi:10.​1084/​jem.​20102660 CrossRef
52.
Zurück zum Zitat Hopper AD, Cross SS, Hurlstone DP, McAlindon ME, Lobo AJ, Hadjivassiliou M, Sloan ME, Dixon S, Sanders DS (2007) Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ 334(7596):729. doi:10.1136/bmj.39133.668681.BE CrossRef Hopper AD, Cross SS, Hurlstone DP, McAlindon ME, Lobo AJ, Hadjivassiliou M, Sloan ME, Dixon S, Sanders DS (2007) Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ 334(7596):729. doi:10.​1136/​bmj.​39133.​668681.​BE CrossRef
53.
Zurück zum Zitat Oberhuber G, Granditsch G, Vogelsang H (1999) The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 11(10):1185–1194CrossRef Oberhuber G, Granditsch G, Vogelsang H (1999) The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 11(10):1185–1194CrossRef
55.
Zurück zum Zitat do Nascimento AB, Fiates GM, Dos Anjos A, Teixeira E (2013) Analysis of ingredient lists of commercially available gluten-free and gluten-containing food products using the text mining technique. Int J Food Sci Nutr 64(2):217–222. doi:10.3109/09637486.2012.718744 CrossRef do Nascimento AB, Fiates GM, Dos Anjos A, Teixeira E (2013) Analysis of ingredient lists of commercially available gluten-free and gluten-containing food products using the text mining technique. Int J Food Sci Nutr 64(2):217–222. doi:10.​3109/​09637486.​2012.​718744 CrossRef
56.
Zurück zum Zitat Santos V, Benassi M, Visentainer J, Matioli G (2010) Quinoa and flaxseed: potential ingredients in the production of bread with functional quality. Braz Arch Biol Tech 53(4):981–986CrossRef Santos V, Benassi M, Visentainer J, Matioli G (2010) Quinoa and flaxseed: potential ingredients in the production of bread with functional quality. Braz Arch Biol Tech 53(4):981–986CrossRef
57.
Zurück zum Zitat Rahaie S, Gharibzahedi SM, Razavi SH, Jafari SM (2014) Recent developments on new formulations based on nutrient-dense ingredients for the production of healthy-functional bread: a review. J Food Sci Technol 51(11):2896–2906. doi:10.1007/s13197-012-0833-6 CrossRef Rahaie S, Gharibzahedi SM, Razavi SH, Jafari SM (2014) Recent developments on new formulations based on nutrient-dense ingredients for the production of healthy-functional bread: a review. J Food Sci Technol 51(11):2896–2906. doi:10.​1007/​s13197-012-0833-6 CrossRef
58.
62.
Zurück zum Zitat Lundin KE, Nilsen EM, Scott HG, Loberg EM, Gjoen A, Bratlie J, Skar V, Mendez E, Lovik A, Kett K (2003) Oats induced villous atrophy in coeliac disease. Gut 52(11):1649–1652CrossRef Lundin KE, Nilsen EM, Scott HG, Loberg EM, Gjoen A, Bratlie J, Skar V, Mendez E, Lovik A, Kett K (2003) Oats induced villous atrophy in coeliac disease. Gut 52(11):1649–1652CrossRef
64.
Zurück zum Zitat Peraaho M, Kaukinen K, Paasikivi K, Sievanen H, Lohiniemi S, Maki M, Collin P (2003) Wheat-starch-based gluten-free products in the treatment of newly detected coeliac disease: prospective and randomized study. Aliment Pharmacol Ther 17(4):587–594. doi:10.1046/j.1365-2036.2003.01425.x CrossRef Peraaho M, Kaukinen K, Paasikivi K, Sievanen H, Lohiniemi S, Maki M, Collin P (2003) Wheat-starch-based gluten-free products in the treatment of newly detected coeliac disease: prospective and randomized study. Aliment Pharmacol Ther 17(4):587–594. doi:10.​1046/​j.​1365-2036.​2003.​01425.​x CrossRef
67.
Zurück zum Zitat Hischenhuber C, Crevel R, Jarry B, Maki M, Moneret-Vautrin DA, Romano A, Troncone R, Ward R (2006) Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease. Aliment Pharmacol Ther 23(5):559–575. doi:10.1111/j.1365-2036.2006.02768.x CrossRef Hischenhuber C, Crevel R, Jarry B, Maki M, Moneret-Vautrin DA, Romano A, Troncone R, Ward R (2006) Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease. Aliment Pharmacol Ther 23(5):559–575. doi:10.​1111/​j.​1365-2036.​2006.​02768.​x CrossRef
68.
Zurück zum Zitat Ciclitira PJ, Ellis HJ, Fagg NL (1984) Evaluation of a gluten free product containing wheat gliadin in patients with coeliac disease. Br Med J (Clin Res Ed) 289(6437):83CrossRef Ciclitira PJ, Ellis HJ, Fagg NL (1984) Evaluation of a gluten free product containing wheat gliadin in patients with coeliac disease. Br Med J (Clin Res Ed) 289(6437):83CrossRef
69.
Zurück zum Zitat Kaukinen K, Collin P, Holm K, Rantala I, Vuolteenaho N, Reunala T, Maki M (1999) Wheat starch-containing gluten-free flour products in the treatment of coeliac disease and dermatitis herpetiformis. A long-term follow-up study. Scand J Gastroenterol 34(2):163–169CrossRef Kaukinen K, Collin P, Holm K, Rantala I, Vuolteenaho N, Reunala T, Maki M (1999) Wheat starch-containing gluten-free flour products in the treatment of coeliac disease and dermatitis herpetiformis. A long-term follow-up study. Scand J Gastroenterol 34(2):163–169CrossRef
70.
Zurück zum Zitat Catassi C, Rossini M, Ratsch IM, Bearzi I, Santinelli A, Castagnani R, Pisani E, Coppa GV, Giorgi PL (1993) Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. Gut 34(11):1515–1519CrossRef Catassi C, Rossini M, Ratsch IM, Bearzi I, Santinelli A, Castagnani R, Pisani E, Coppa GV, Giorgi PL (1993) Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. Gut 34(11):1515–1519CrossRef
71.
Zurück zum Zitat Catassi C, Fabiani E, Iacono G, D’Agate C, Francavilla R, Biagi F, Volta U, Accomando S, Picarelli A, De Vitis I, Pianelli G, Gesuita R, Carle F, Mandolesi A, Bearzi I, Fasano A (2007) A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr 85(1):160–166. Catassi C, Fabiani E, Iacono G, D’Agate C, Francavilla R, Biagi F, Volta U, Accomando S, Picarelli A, De Vitis I, Pianelli G, Gesuita R, Carle F, Mandolesi A, Bearzi I, Fasano A (2007) A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr 85(1):160–166.
72.
Zurück zum Zitat Leffler D, Schuppan D, Pallav K, Najarian R, Goldsmith JD, Hansen J, Kabbani T, Dennis M, Kelly CP (2013) Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut 62(7):996–1004. doi:10.1136/gutjnl-2012-302196 CrossRef Leffler D, Schuppan D, Pallav K, Najarian R, Goldsmith JD, Hansen J, Kabbani T, Dennis M, Kelly CP (2013) Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut 62(7):996–1004. doi:10.​1136/​gutjnl-2012-302196 CrossRef
73.
Zurück zum Zitat Food and Drug Administration (2011) Health hazard assessment for gluten exposure in individuals with celiac disease: determination of tolerable daily intake levels and levels of concern for gluten. Office of Food Safety/Center of Food Safety and Applied Nutrition, Food and Drug Administration, USA Food and Drug Administration (2011) Health hazard assessment for gluten exposure in individuals with celiac disease: determination of tolerable daily intake levels and levels of concern for gluten. Office of Food Safety/Center of Food Safety and Applied Nutrition, Food and Drug Administration, USA
74.
Zurück zum Zitat Food and Agriculture Organization/World Health Organization (FAO/WHO) (2008) Codex Committee on Nutrition and Foods for Special Dietary Uses. Codex standard for foods for special dietary use for persons intolerant to gluten. World Health Organization, Rome Food and Agriculture Organization/World Health Organization (FAO/WHO) (2008) Codex Committee on Nutrition and Foods for Special Dietary Uses. Codex standard for foods for special dietary use for persons intolerant to gluten. World Health Organization, Rome
75.
Zurück zum Zitat Minister of Justice Canada (2015) Food and drug regulations. C.R.C., c. 870. B part. Foods. Foods for special dietary use Minister of Justice Canada (2015) Food and drug regulations. C.R.C., c. 870. B part. Foods. Foods for special dietary use
76.
Zurück zum Zitat Food and Drug Administration (2013) Food labeling: gluten-free labeling of foods. Final Rule 78(150):47154–47179 Food and Drug Administration (2013) Food labeling: gluten-free labeling of foods. Final Rule 78(150):47154–47179
77.
Zurück zum Zitat Ministerio de Salud Argentina (2015) Directrices para la Autorización de un Alimento Libre de Gluten. Programa Federal de control de Alimentos. Conal, Acta 106, Abril 14, 2015. Buenos Aires, Argentina Ministerio de Salud Argentina (2015) Directrices para la Autorización de un Alimento Libre de Gluten. Programa Federal de control de Alimentos. Conal, Acta 106, Abril 14, 2015. Buenos Aires, Argentina
78.
Zurück zum Zitat Food Standards in Australia and New Zealand (2012) Nutrition information user guide to standard 1.2.8, Nutrition information requirements. Part B, Nutrition Claims, Australia Food Standards in Australia and New Zealand (2012) Nutrition information user guide to standard 1.2.8, Nutrition information requirements. Part B, Nutrition Claims, Australia
79.
Zurück zum Zitat Instituto de Salud Pública (1997) Reglamento Sanitario de los Alimentos (RSA), Articulos 516–518. ISP, Santiago Instituto de Salud Pública (1997) Reglamento Sanitario de los Alimentos (RSA), Articulos 516–518. ISP, Santiago
80.
Zurück zum Zitat Gibert A, Espadaler M, Angel Canela M, Sanchez A, Vaque C, Rafecas M (2006) Consumption of gluten-free products: should the threshold value for trace amounts of gluten be at 20, 100 or 200 p.p.m.? Eur J Gastroenterol Hepatol 18(11):1187–1195. doi:10.1097/01.meg.0000236884.21343.e4 CrossRef Gibert A, Espadaler M, Angel Canela M, Sanchez A, Vaque C, Rafecas M (2006) Consumption of gluten-free products: should the threshold value for trace amounts of gluten be at 20, 100 or 200 p.p.m.? Eur J Gastroenterol Hepatol 18(11):1187–1195. doi:10.​1097/​01.​meg.​0000236884.​21343.​e4 CrossRef
81.
Zurück zum Zitat Gibert A, Kruizinga AG, Neuhold S, Houben GF, Canela MA, Fasano A, Catassi C (2012) Might gluten traces in wheat substitutes pose a risk in patients with celiac disease? A population-based probabilistic approach to risk estimation. Am J Clin Nutr 97(1):109–116. doi:10.3945/ajcn.112.047985 CrossRef Gibert A, Kruizinga AG, Neuhold S, Houben GF, Canela MA, Fasano A, Catassi C (2012) Might gluten traces in wheat substitutes pose a risk in patients with celiac disease? A population-based probabilistic approach to risk estimation. Am J Clin Nutr 97(1):109–116. doi:10.​3945/​ajcn.​112.​047985 CrossRef
82.
Zurück zum Zitat Theethira TG, Dennis M (2015) Celiac disease and the gluten-free diet: consequences and recommendations for improvement. Dig Dis 33(2):175–182. doi:10.1159/000369504 CrossRef Theethira TG, Dennis M (2015) Celiac disease and the gluten-free diet: consequences and recommendations for improvement. Dig Dis 33(2):175–182. doi:10.​1159/​000369504 CrossRef
83.
Zurück zum Zitat Diamanti A, Capriati T, Basso MS, Panetta F, Di Ciommo Laurora VM, Bellucci F, Cristofori F, Francavilla R (2014) Celiac disease and overweight in children: an update. Nutrients 6(1):207–220. doi:10.3390/nu6010207 CrossRef Diamanti A, Capriati T, Basso MS, Panetta F, Di Ciommo Laurora VM, Bellucci F, Cristofori F, Francavilla R (2014) Celiac disease and overweight in children: an update. Nutrients 6(1):207–220. doi:10.​3390/​nu6010207 CrossRef
84.
Zurück zum Zitat Mariani P, Viti MG, Montuori M, La Vecchia A, Cipolletta E, Calvani L, Bonamico M (1998) The gluten-free diet: a nutritional risk factor for adolescents with celiac disease? J Pediatr Gastroenterol Nutr 27(5):519–523CrossRef Mariani P, Viti MG, Montuori M, La Vecchia A, Cipolletta E, Calvani L, Bonamico M (1998) The gluten-free diet: a nutritional risk factor for adolescents with celiac disease? J Pediatr Gastroenterol Nutr 27(5):519–523CrossRef
86.
Zurück zum Zitat Norsa L, Shamir R, Zevit N, Verduci E, Hartman C, Ghisleni D, Riva E, Giovannini M (2013) Cardiovascular disease risk factor profiles in children with celiac disease on gluten-free diets. World J Gastroenterol 19(34):5658–5664. doi:10.3748/wjg.v19.i34.5658 CrossRef Norsa L, Shamir R, Zevit N, Verduci E, Hartman C, Ghisleni D, Riva E, Giovannini M (2013) Cardiovascular disease risk factor profiles in children with celiac disease on gluten-free diets. World J Gastroenterol 19(34):5658–5664. doi:10.​3748/​wjg.​v19.​i34.​5658 CrossRef
87.
Zurück zum Zitat Kabbani TA, Goldberg A, Kelly CP, Pallav K, Tariq S, Peer A, Hansen J, Dennis M, Leffler DA (2012) Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment Pharmacol Ther 35(6):723–729. doi:10.1111/j.1365-2036.2012.05001.x CrossRef Kabbani TA, Goldberg A, Kelly CP, Pallav K, Tariq S, Peer A, Hansen J, Dennis M, Leffler DA (2012) Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment Pharmacol Ther 35(6):723–729. doi:10.​1111/​j.​1365-2036.​2012.​05001.​x CrossRef
90.
Zurück zum Zitat Botero-Lopez JE, Araya M, Parada A, Mendez MA, Pizarro F, Espinosa N, Canales P, Alarcon T (2011) Micronutrient deficiencies in patients with typical and atypical celiac disease. J Pediatr Gastroenterol Nutr 53(3):265–270. doi:10.1097/MPG.0b013e3181f988fc CrossRef Botero-Lopez JE, Araya M, Parada A, Mendez MA, Pizarro F, Espinosa N, Canales P, Alarcon T (2011) Micronutrient deficiencies in patients with typical and atypical celiac disease. J Pediatr Gastroenterol Nutr 53(3):265–270. doi:10.​1097/​MPG.​0b013e3181f988fc​ CrossRef
91.
Zurück zum Zitat McGough N, Cummings JH (2005) Coeliac disease: a diverse clinical syndrome caused by intolerance of wheat, barley and rye. Proc Nutr Soc 64(4):434–450. doi:10.1079/PNS2005461 CrossRef McGough N, Cummings JH (2005) Coeliac disease: a diverse clinical syndrome caused by intolerance of wheat, barley and rye. Proc Nutr Soc 64(4):434–450. doi:10.​1079/​PNS2005461 CrossRef
93.
Zurück zum Zitat Oyarzún A, Nakash T, Ayala J, Lucero Y, Araya M (2015) Following gluten free diet: less available, higher cost and poor nutritional profile of gluten-free school snacks. Int J Celiac Dis 3(3):102–107CrossRef Oyarzún A, Nakash T, Ayala J, Lucero Y, Araya M (2015) Following gluten free diet: less available, higher cost and poor nutritional profile of gluten-free school snacks. Int J Celiac Dis 3(3):102–107CrossRef
94.
Zurück zum Zitat Wierdsma NJ, van Bokhorst-de van der Schueren MA, Berkenpas M, Mulder CJ, van Bodegraven AA (2013) Vitamin and mineral deficiencies are highly prevalent in newly diagnosed celiac disease patients. Nutrients 5(10):3975–3992. doi:10.3390/nu5103975 CrossRef Wierdsma NJ, van Bokhorst-de van der Schueren MA, Berkenpas M, Mulder CJ, van Bodegraven AA (2013) Vitamin and mineral deficiencies are highly prevalent in newly diagnosed celiac disease patients. Nutrients 5(10):3975–3992. doi:10.​3390/​nu5103975 CrossRef
95.
Zurück zum Zitat Salazar Quero JC, Espin Jaime B, Rodriguez Martinez A, Arguelles Martin F, Garcia Jimenez R, Rubio Murillo M, Pizarro Martin A (2015) Nutritional assessment of gluten-free diet. Is gluten-free diet deficient in some nutrient? An Pediatr (Barc) 83(1):33–39. doi:10.1016/j.anpedi.2014.08.011 CrossRef Salazar Quero JC, Espin Jaime B, Rodriguez Martinez A, Arguelles Martin F, Garcia Jimenez R, Rubio Murillo M, Pizarro Martin A (2015) Nutritional assessment of gluten-free diet. Is gluten-free diet deficient in some nutrient? An Pediatr (Barc) 83(1):33–39. doi:10.​1016/​j.​anpedi.​2014.​08.​011 CrossRef
97.
Zurück zum Zitat Koerner TB, Cleroux C, Poirier C, Cantin I, La Vieille S, Hayward S, Dubois S (2013) Gluten contamination of naturally gluten-free flours and starches used by Canadians with celiac disease. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 30(12):2017–2021. doi:10.1080/19440049.2013.840744 CrossRef Koerner TB, Cleroux C, Poirier C, Cantin I, La Vieille S, Hayward S, Dubois S (2013) Gluten contamination of naturally gluten-free flours and starches used by Canadians with celiac disease. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 30(12):2017–2021. doi:10.​1080/​19440049.​2013.​840744 CrossRef
98.
Zurück zum Zitat Crowe JP, Falini NP (2001) Gluten in pharmaceutical products. Am J Health Syst Pharm 58(5):396–401 Crowe JP, Falini NP (2001) Gluten in pharmaceutical products. Am J Health Syst Pharm 58(5):396–401
99.
Zurück zum Zitat Leffler DA, Dennis M, Edwards George JB, Jamma S, Magge S, Cook EF, Schuppan D, Kelly CP (2009) A simple validated gluten-free diet adherence survey for adults with celiac disease. Clin Gastroenterol Hepatol 7(5):530–536, 536 e531–532. doi:10.1016/j.cgh.2008.12.032 Leffler DA, Dennis M, Edwards George JB, Jamma S, Magge S, Cook EF, Schuppan D, Kelly CP (2009) A simple validated gluten-free diet adherence survey for adults with celiac disease. Clin Gastroenterol Hepatol 7(5):530–536, 536 e531–532. doi:10.​1016/​j.​cgh.​2008.​12.​032
100.
Zurück zum Zitat Vahedi K, Mascart F, Mary JY, Laberenne JE, Bouhnik Y, Morin MC, Ocmant A, Velly C, Colombel JF, Matuchansky C (2003) Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 98(5):1079–1087. doi:10.1111/j.1572-0241.2003.07284.x CrossRef Vahedi K, Mascart F, Mary JY, Laberenne JE, Bouhnik Y, Morin MC, Ocmant A, Velly C, Colombel JF, Matuchansky C (2003) Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 98(5):1079–1087. doi:10.​1111/​j.​1572-0241.​2003.​07284.​x CrossRef
102.
Zurück zum Zitat Biagi F, Bianchi PI, Marchese A, Trotta L, Vattiato C, Balduzzi D, Brusco G, Andrealli A, Cisaro F, Astegiano M, Pellegrino S, Magazzu G, Klersy C, Corazza GR (2012) A score that verifies adherence to a gluten-free diet: a cross-sectional, multicentre validation in real clinical life. Br J Nutr 108(10):1884–1888. doi:10.1017/S0007114511007367 CrossRef Biagi F, Bianchi PI, Marchese A, Trotta L, Vattiato C, Balduzzi D, Brusco G, Andrealli A, Cisaro F, Astegiano M, Pellegrino S, Magazzu G, Klersy C, Corazza GR (2012) A score that verifies adherence to a gluten-free diet: a cross-sectional, multicentre validation in real clinical life. Br J Nutr 108(10):1884–1888. doi:10.​1017/​S000711451100736​7 CrossRef
103.
Zurück zum Zitat Comino I, Real A, Vivas S, Siglez MA, Caminero A, Nistal E, Casqueiro J, Rodriguez-Herrera A, Cebolla A, Sousa C (2012) Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces. Am J Clin Nutr 95(3):670–677. doi:10.3945/ajcn.111.026708 CrossRef Comino I, Real A, Vivas S, Siglez MA, Caminero A, Nistal E, Casqueiro J, Rodriguez-Herrera A, Cebolla A, Sousa C (2012) Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces. Am J Clin Nutr 95(3):670–677. doi:10.​3945/​ajcn.​111.​026708 CrossRef
104.
Zurück zum Zitat Moron B, Bethune MT, Comino I, Manyani H, Ferragud M, Lopez MC, Cebolla A, Khosla C, Sousa C (2008) Toward the assessment of food toxicity for celiac patients: characterization of monoclonal antibodies to a main immunogenic gluten peptide. PLoS One 3(5):e2294. doi:10.1371/journal.pone.0002294 CrossRef Moron B, Bethune MT, Comino I, Manyani H, Ferragud M, Lopez MC, Cebolla A, Khosla C, Sousa C (2008) Toward the assessment of food toxicity for celiac patients: characterization of monoclonal antibodies to a main immunogenic gluten peptide. PLoS One 3(5):e2294. doi:10.​1371/​journal.​pone.​0002294 CrossRef
105.
Zurück zum Zitat Moron B, Cebolla A, Manyani H, Alvarez-Maqueda M, Megias M, Thomas Mdel C, Lopez MC, Sousa C (2008) Sensitive detection of cereal fractions that are toxic to celiac disease patients by using monoclonal antibodies to a main immunogenic wheat peptide. Am J Clin Nutr 87(2):405–414. Moron B, Cebolla A, Manyani H, Alvarez-Maqueda M, Megias M, Thomas Mdel C, Lopez MC, Sousa C (2008) Sensitive detection of cereal fractions that are toxic to celiac disease patients by using monoclonal antibodies to a main immunogenic wheat peptide. Am J Clin Nutr 87(2):405–414.
106.
Zurück zum Zitat Moreno ML, Cebolla A, Munoz-Suano A, Carrillo-Carrion C, Comino I, Pizarro A, Leon F, Rodriguez-Herrera A, Sousa C (2015) Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing. Gut. doi:10.1136/gutjnl-2015-310148 Moreno ML, Cebolla A, Munoz-Suano A, Carrillo-Carrion C, Comino I, Pizarro A, Leon F, Rodriguez-Herrera A, Sousa C (2015) Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing. Gut. doi:10.​1136/​gutjnl-2015-310148
108.
Zurück zum Zitat Hallert C, Granno C, Grant C, Hulten S, Midhagen G, Strom M, Svensson H, Valdimarsson T, Wickstrom T (1998) Quality of life of adult coeliac patients treated for 10 years. Scand J Gastroenterol 33(9):933–938CrossRef Hallert C, Granno C, Grant C, Hulten S, Midhagen G, Strom M, Svensson H, Valdimarsson T, Wickstrom T (1998) Quality of life of adult coeliac patients treated for 10 years. Scand J Gastroenterol 33(9):933–938CrossRef
109.
Zurück zum Zitat Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM, Santed R, Valderas JM, Ribera A, Domingo-Salvany A, Alonso J (2005) The Spanish version of the Short Form 36 Health Survey: a decade of experience and new developments. Gac Sanit 19(2):135–150. doi: 10.1590/S0213-91112005000200007 CrossRef Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM, Santed R, Valderas JM, Ribera A, Domingo-Salvany A, Alonso J (2005) The Spanish version of the Short Form 36 Health Survey: a decade of experience and new developments. Gac Sanit 19(2):135–150. doi: 10.​1590/​S0213-9111200500020000​7 CrossRef
111.
Zurück zum Zitat Zarkadas M, Cranney A, Case S, Molloy M, Switzer C, Graham ID, Butzner JD, Rashid M, Warren RE, Burrows V (2006) The impact of a gluten-free diet on adults with coeliac disease: results of a national survey. J Hum Nutr Diet 19(1):41–49. doi:10.1111/j.1365-277X.2006.00659.x CrossRef Zarkadas M, Cranney A, Case S, Molloy M, Switzer C, Graham ID, Butzner JD, Rashid M, Warren RE, Burrows V (2006) The impact of a gluten-free diet on adults with coeliac disease: results of a national survey. J Hum Nutr Diet 19(1):41–49. doi:10.​1111/​j.​1365-277X.​2006.​00659.​x CrossRef
112.
Zurück zum Zitat Nachman F, Maurino E, Vazquez H, Sfoggia C, Gonzalez A, Gonzalez V, Plancer del Campo M, Smecuol E, Niveloni S, Sugai E, Mazure R, Cabanne A, Bai JC (2009) Quality of life in celiac disease patients: prospective analysis on the importance of clinical severity at diagnosis and the impact of treatment. Dig Liver Dis 41(1):15–25. doi:10.1016/j.dld.2008.05.011 CrossRef Nachman F, Maurino E, Vazquez H, Sfoggia C, Gonzalez A, Gonzalez V, Plancer del Campo M, Smecuol E, Niveloni S, Sugai E, Mazure R, Cabanne A, Bai JC (2009) Quality of life in celiac disease patients: prospective analysis on the importance of clinical severity at diagnosis and the impact of treatment. Dig Liver Dis 41(1):15–25. doi:10.​1016/​j.​dld.​2008.​05.​011 CrossRef
Metadaten
Titel
Celiac disease: understanding the gluten-free diet
verfasst von
Karla A. Bascuñán
María Catalina Vespa
Magdalena Araya
Publikationsdatum
22.06.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 2/2017
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-016-1238-5

Weitere Artikel der Ausgabe 2/2017

European Journal of Nutrition 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.